Summit Global Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.25M	Sell	17,083 -7,721	-31%	-$1.02M	0.13%	83
2025 Q4	$3.52M	Sell	24,804 -11,351	-31%	-$1.64M	0.21%	56
2025 Q3	$5.08M	Buy	36,155 +24,639	+214%	+$3.34M	0.3%	53
2025 Q2	$1.45M	Buy	11,516 +638	+6%	+$73.2K	0.09%	136
2025 Q1	$1.2M	Sell	10,878 -21,182	-66%	-$2.68M	0.09%	138
2024 Q4	$4.38M	Sell	32,060 -21,517	-40%	-$2.66M	0.27%	81
2024 Q3	$6.17M	Sell	53,577 -24,024	-31%	-$3.29M	0.39%	54
2024 Q2	$10.7M	Buy	77,601 +28,124	+57%	+$3.86M	0.72%	28
2024 Q1	$6.82M	Buy	49,477 +8,744	+21%	+$1.19M	0.51%	46
2023 Q4	$5.37M	Buy	40,733 +10,696	+36%	+$1.23M	0.35%	66
2023 Q3	$3.38M	Buy	30,037 +406	+1%	+$42.8K	0.23%	96
2023 Q2	$2.79M	Buy	29,631 +646	+2%	+$63.1K	0.19%	115
2023 Q1	$2.93M	Buy	28,985 +2,309	+9%	+$240K	0.23%	105
2022 Q4	$3.19M	Buy	26,676 +14,979	+128%	+$1.75M	0.27%	103
2022 Q3	$1.24M	Buy	+11,697	New	+$1.19M	0.11%	174